Stocks
Anavex Life Sciences Corp.AVXL
NASDAQHealthcareBiotechnology$4.65+0.00%
Focused on developing treatments for neurodegenerative and neurodevelopmental disorders, this biopharmaceutical company is known for its lead candidate targeting Alzheimer's disease and Rett syndrome. Investors monitor its clinical-stage pipeline due to the high unmet medical need in these therapeutic areas.
Market Cap: $430.9M52W Range: $2.86 – $13.99
Congressional Interest in Anavex Life Sciences Corp. (AVXL)
1 member of Congress has disclosed 2 trades in Anavex Life Sciences Corp. (AVXL), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 1 sale. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
2
Unique Politicians
1
Buys
1
Sells
1
Who in Congress Is Trading AVXL?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2022-12-12 | Christopher L. Jacobs | sell | $1K – $15K |
| 2022-10-12 | Christopher L. Jacobs | buy | $1K – $15K |